About Hallym University Kangnam Sacred Heart Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Hallym University Kangnam Sacred Heart Hospital
During the past decade, Hallym University Kangnam Sacred Heart Hospital conducted 64 clinical trials. In the 10-year time frame, 64 clinical trials started and 18 clinical trials were completed, i.e. on
average, 28.1% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 14 clinical trials were completed. i.e. 73.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
2000-10-01
2019-11-01
Completed
1,772
Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
2002-05-01
2014-06-01
Completed
3,871
S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer
2004-04-01
2018-10-01
Completed
695
Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
2004-02-01
2012-11-01
Completed
3,397
S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
2006-08-01
2016-02-01
Completed
1,038
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
2005-08-04
2022-12-01
Active, not recruiting
3,610
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
2005-11-01
2018-01-01
Completed
2,334
Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal Cancer
2006-02-17
2019-02-11
Terminated
355
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Hallym University Kangnam Sacred Heart Hospital" #1 sponsor was "Hallym University Kangnam Sacred Heart Hospital" with 16 trials, followed by "Pfizer" with 9 trials
sponsored, "Eli Lilly and Company" with 7 trials sponsored, "Janssen Research & Development, LLC" with 5 trials sponsored and "Bayer"
with 5 trials sponsored. Other sponsors include 33 different institutions and
companies that sponsored additional 35 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hallym University Kangnam Sacred Heart Hospital"
#1 collaborator was "CardioVascular Research Foundation, Korea" with 3 trials as a collaborator, "Ajou University School of Medicine" with 2 trials as a collaborator, "Dermira, Inc." with 2 trials as a collaborator, "Hallym University Kangnam Sacred Heart Hospital" with 2 trials as a collaborator and "Incyte Corporation" with 2 trials as a collaborator. Other collaborators include 16 different institutions and companies that were
collaborators in the rest 25 trials.
Clinical Trials Conditions at Hallym University Kangnam Sacred Heart Hospital
According to Clinical.Site data, the most researched conditions in "Hallym University Kangnam Sacred Heart Hospital" are
"Atopic Dermatitis" (6 trials), "COVID-19" (4 trials), "Dermatitis, Atopic" (3 trials), "Hepatitis B" (3 trials) and "Influenza A" (3 trials). Many other conditions were trialed in "Hallym University Kangnam Sacred Heart Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Hallym University Kangnam Sacred Heart Hospital
Most popular intervention types in "Hallym University Kangnam Sacred Heart Hospital" are "Drug" (45 trials), "Other" (13 trials), "Biological" (10 trials), "Device" (5 trials) and "Behavioral" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (19 trials), "Baricitinib" (2 trials), "Clevudine" (2 trials), "Finerenone (BAY94-8862)" (2 trials) and "Lebrikizumab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Hallym University Kangnam Sacred Heart Hospital
The vast majority of trials in "Hallym University Kangnam Sacred Heart Hospital" are
67 trials for "All" genders, 6 trials for "Female" genders and 4 trials for "Male" genders.
Clinical Trials Status at Hallym University Kangnam Sacred Heart Hospital
Currently, there are NaN active trials in "Hallym University Kangnam Sacred Heart Hospital".
undefined are not yet recruiting,
8 are recruiting,
6 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 46 completed trials in Hallym University Kangnam Sacred Heart Hospital,
undefined suspended trials,
and 5 terminated clinical trials to date.
Out of the total trials that were conducted in Hallym University Kangnam Sacred Heart Hospital, 2 "Phase 1"
clinical trials were conducted, 10 "Phase 2" clinical
trials and 23 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 13 trials, and there were
also 14 trials that are defined as “Not Applicable".